Spectrofluorimetric study of 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2H-benzo (a) quinolizine-2-spiro-3'- (1'-phenyl) succinimide hydrochloride
Coronel, C.; Ballesteros, M.; del Castillo, B.; Söllhuber, M.M.; Menendez, J.C.
Journal de Pharmacie de Belgique 43(1): 37-45
1988
ISSN/ISBN: 0047-2166 PMID: 3379561 Document Number: 324759
Document emailed within 1 workday
Related Documents
Sarles, H.; Camatte, R. 1970: Therapeutic action of phenyl-dimethoxy-2'-4' phenyl-methyl-carbinol and of a vesicular endothelium extract in dyspeptic disorders, fat intolerance and steatorrhea Marseille Medical 107(6): 513-516Dhar, J.D.; Setty, B.S.; Duran, S.; Kapil, R.S. 1991: Biological profile of 2-[4-(2-N-piperidinoethoxy) phenyl]-3-phenyl (2H) benzo (b) pyran--a potent antiimplantation agent in rat Contraception 44(4): 461-472
Grochowski, J.; Serda, P.; Brandt, K. 1994: Structural investigation of the new potent DNA alkylator spiro(2H-1,3,2-benzodiazaphosphole-2,2',lambda 5 [1,3,5,2,4,6] triazatriphosphorine),4',4',6',6'-tetrakis(1-aziridinyl)-1,3,4',4',6', 6',-hexahydro Arzneimittel-Forschung 44(5): 655-658
Dua, P.R.; Chatterji, S.K. 1981: Anticonvulsant activity of 3-p-chlorophenoxy-1-n (3,4 dimethoxy phenyl) piperazinopropanol-2 (compound 65/359) Indian Journal of Experimental Biology 19(11): 1047-1049
Shafik, R.M.; Ibrahim, E.A.; el-Khawass, E.M.; el-Hawash, S.A.; el-Dardiry, S.A. 1989: Synthesis of some 2-(3,4-dimethoxy-phenyl)-1,3-propanediamines as potential dopaminergic agents Die Pharmazie 44(2): 115-118
Bianchi, M.; Butti, A.; Pfeiffer, U.; Rossi, S.; Barzaghi, F.; Marcaria, V.; Nencioni, A. 1986: Compounds with anti-gastric secretion and antiulcer activity. V. Derivatives of 3,3,4a,6,7,11b-hexahydro-2H,5H-benzo [1,4]cyclohep[1,2-b][1,4]-oxazine and related products Il Farmaco; Edizione Scientifica 41(3): 229-256
Shimamine, M.; Takahashi, K.; Nakahara, Y. 1989: Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetamine (DOB) and 2,5-dimethoxy-4-ethylamphetamine (DOET) Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1989(107): 113-119
Ali, M.A.; Ismail, R.; Choon, T.S.; Yoon, Y.K.; Wei, A.C.; Pandian, S.; Samy, J.G.; De Clercq, E.; Pannecouque, C. 2011: Synthesis and anti-HIV activity of novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]isoxazole analogues Acta Poloniae Pharmaceutica 68(3): 343-348
Henesey, C.M.; Kellner-Weibel, G.L.; Tarloff, J.B.; Harvison, P.J. 1999: Comparative disposition of the nephrotoxicant N-(3, 5-dichlorophenyl)succinimide and the non-nephrotoxicant N-(3, 5-difluorophenyl)succinimide in Fischer 344 rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(6): 674-680
Okayama, T.; Araki, S.; Miyamae, T.; Morita, Y.; Morikawa, T.; Hagiwara, M. 1997: Anticoagulant activity of the novel thrombin inhibitor 1-butyl-3-(6,7-dimethoxy-2-naphthylsulfonyl) amino-3-(3-guanidinopropyl)-2-pyrrolidinone hydrochloride Arzneimittel-Forschung 47(9): 1023-1026
Grubb, M.F.; Diamond, S.; Christ, D.D. 1997: In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(12): 1424-1428
Obniska, J.; Pawłowski, M.; Kołaczkowski, M.; Czopek, A.; Duszyńska, B.; Klodzińska, A.; Tatarczyńska, E.; Chojnacka-Wójcik, E. 2003: Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione Polish Journal of Pharmacology 55(4): 553-557
Diurno, M.V.; Cristinziano, A.; Mazzoni, O.; Piscopo, E.; Bolognese, A. 1995: Synthesis and antimicrobial activity of 1-(p-substituted)phenyl-3-(p-alkoxy)phenyl-4-phenyl-azetidin-2-ones Farmaco 50(2): 143-148
Avakian, O.M.; Kaltrikian, A.A.; Stepanian, N.O. 1979: Aspects of the action of odiphaline hydrochloride 3-phenyl-3-O-hydroxyphenyl-N-(phenylisopropyl) propylamine on the cardiovascular system Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny 19(4): 9-14
Lynch, J.; Montgomery, D.; Ventura, A.; Wilber, D.; Lucchesi, B.R. 1986: Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride Arzneimittel-Forschung 36(3): 475-481
Veselá, J.; Drsata, J. 1988: The effect of 5-[2-(N,N-dimethylamino)ethoxy]-7-oxo-7H-benzo(c) fluorene hydrochloride (Benfluron, a cytostatic) on ornithine decarboxylase activity in the regenerating rat liver in vivo Ceskoslovenska Farmacie 37(6): 251-254
Karim, M.Zahidul.; Gu, Z.; Sawada, A.; Taniguchi, T.; Kawase, K.; Yamamoto, T.; Kitazawa, Y. 2002: Neuroprotective effects of R(-)-1-(benzo[b]thiophen-5-yl)-2- [2-(N,N-diethylamino)ethoxy]ethanol hydrochloride (T-588) against retinal ganglion cell death induced by elevated intraocular pressure in rat Japanese Journal of Ophthalmology 46(6): 621-626
Sergienko, N.G.; Luchko, N.A.; Brovina, N.N. 1981: Spectrofluorimetric study of interaction between acetylcholine and brain proteins Ukrainskii Biokhimicheskii Zhurnal 53(3): 18-21
Vollmer, K.O.; Koss, F.W. 1970: Synthesis of DL-trans-2-dimethylamino-i-phenyl-cyclohex-3-en-trans-1-carboxylic acid ethyl ester-(6-14C)-hydrochloride Arzneimittel-Forschung 20(8): 990-992
El-Telbany, F.A.; Ghoneim, K.M.; Khalifa, M. 1976: Synthesis of certain spiro compounds for pharmacological study. Part Ii Journal de Pharmacie de Belgique 31(4): 403-410